Founder and Chair – Boston, MA

Senan is a physician-scientist and entrepreneur dedicated to creating technology to improve global health. He has an MD and PhD from Harvard in Computational Neuroscience, in which he applied machine learning approaches for seizure prediction in epilepsy. He is on the board of nonprofit organizations supporting community health, including The Connected Foundation and Medicine in Motion. He also founded Delfina to bring lifesaving technologies to pregnancy care. Senan enjoys surfing, riding bikes, and listening to deep house mixes.

CEO - Boston, MA

Hassaan Ebrahim is an educator and entrepreneur focused on improving outcomes for children around the world. In addition to leading the team at Hikma Health, Hassaan is an education consultant at Education Resource Strategies, a non-profit supporting public school districts across the country. Prior to graduate school, he taught high school math in his hometown of San Jose, CA. Hassaan has a Masters in Public Policy from the Harvard Kennedy School and a bachelors in neuroscience from the University of Southern California. Hassaan enjoys biking around Boston and developing his photography and pottery skills.

Chief Technology Officer - Phoenix, AZ

Ally is a software engineer by training with a deep expertise in mathematics, data science, artificial intelligence, and machine learning. He is the co-founder of Elsa Health, a mission-driven company focused on leveraging technology and AI to achieve equitable, universal healthcare. He has led the development of multiple, large-scale projects using emerging technologies across a range of sectors, including healthcare and education. Ally teaches practical training programs for emerging data scientists and writes about software engineering and AI. He has also been featured at international conferences such as Conference on Neural Information Processing Systems (NEURIPS), and contributes to the ITU/WHO focus group on AI for Health. He is constantly looking for ways to improve the human condition and contribute meaningfully to society.

Chief Research Officer - Boston, MA

Henry Ashworth, MD, MPH is a Resident Physician in Emergency Medicine. While at Harvard Medical School, Henry received the Sheldon Fellowship to study the implementation of disruptive innovations in low-resource settings. His previous work has focused on researching healthcare inequities internationally and building community emergency response teams in post-earthquake Nepal as a Fulbright Fellow. Henry leads multiple research projects at Hikma Health to rigorously assess the impact of our technology on the populations we serve. Outside of work, he enjoys dancing of any kind, any aquatic activity, and culinary adventures.

Chief Medical Officer - Baltimore, MD

Dr. Michael Chilazi is a Cardiology Fellow at Mass. General Hospital. His family immigrated from Aleppo, Syria which he traveled to annually to visit relatives. He studied Neuroscience and Arabic at Harvard College before earning his medical degree at Harvard Medical School and completing his residency in Internal Medicine at Johns Hopkins Hospital. Michael is passionate about supporting medical education and healthcare delivery domestically and internationally, having worked with both Kaiser Permanente and the Syrian American Medical Society. In his free time, Michael enjoys traveling, cooking, and (occasionally) running.

Chief Operating Officer - Boston, MA

Zahra is the Associate Director of Health Economics and Outcomes Research at Vertex Pharmaceuticals, where she leads quantitative evidence generation studies to support global market access and reimbursement of their Cystic Fibrosis portfolio. Zahra holds a M.S. in Health Economics from the Harvard School of Public Health and a B.S./B.A. in Biological Sciences and Middle Eastern Studies from Columbia University. She is passionate about the intersection of health and data access disparities and enjoys singing, Arabic calligraphy, and pretending to write poetry.n goes here

Chief Financial Officer - Denver, CO

Melissa Shelton is a Denver native, currently working as a Compliance and Privacy Specialist at Children's Hospital Colorado. She is certified in both Healthcare Compliance (CHC) and Healthcare Privacy Compliance (CHPC). With a passion to gain new experiences that have a focus on justice and health equity, she serves on the board of a volunteer organization that focuses on meeting the unmet medical needs of vulnerable populations in her community. She firmly believes that access to healthcare is a basic human right, not a privilege. When she is not working or volunteering, you can find her teaching yoga or leading a local run club.

Program Director - Arusha, Tanzania

Sarah is a global health professional committed to empowering communities in resource-limited settings, particularly for women and girls. She graduated from Arizona State University with a degree in Global Health and is currently pursuing her MPH from George Washington University. She has led SRH programs and HIV stigma reduction in Tanzania and the United States. Her additional work in emergency management inspires her to pursue a career reducing health disparities for marginalized and displaced populations, with a specific interest in maternal health. In her free time, Sarah can be found on safari, eating Mexican food, and playing with her dogs Amadeo and Theo.

Director of Development - San Francisco, CA

Sasha Nouri is a development professional with a decade of experience working in nonprofits, educational institutions, and medical centers. As a fundraiser, she enjoys cultivating sincere and authentic relationships with donors. Sasha feels privileged to support our mission and profound impact on migrant and displaced patients. Outside of work, you can find her playing pickleball, birdwatching, and adventuring in the beautiful Bay Area.

Dr. Isaac Samuel Kohane is the Chair of the Department of Biomedical Informatics at Harvard Medical School. He applies computational techniques, whole-genome analysis, and functional genomics to study human diseases through the developmental lens, and particularly through the use of animal model systems. Kohane has led the use of whole healthcare systems, notably in the i2b2 project, as “living laboratories” to drive discovery research and comparative effectiveness with software and methods adopted in over 84 academic health centers internationally.

Sylvia Kehlenbrink is an Endocrinologist and Director of Global Endocrinology at Brigham and Women’s Hospital, part-time Instructor at Harvard Medical School, and Founder and Director of the Non-Communicable Diseases (NCDs) in Conflict Program at the Harvard Humanitarian Initiative. She graduated from medical school at the Charité-Universitätsmedizin in Berlin, Germany, completed her residency training in Social Internal Medicine at Montefiore Medical Center in New York and her fellowship in Endocrinology at Brigham and Women’s Hospital in Boston. Her research focus is on diabetes care in humanitarian crises and improving insulin access in low and middle-income settings.

Steve Goodman is the head of drug product manufacturing at Bluebird Bio, where he oversees the production of cellular therapies across their portfolio of products and is accountable for the long-term technology strategy to expand access of these treatments to serve global patient requirements. Before joining Bluebird in January 2018, Steve was at GSK where he held a number of roles across research, development, manufacturing and supply chain. These included roles leading cross-functional teams in the design, development and transfer of clinical and commercial chemical manufacturing processes; designing and implementing supply chain strategies for ex vivo and in vivo gene-modified cell therapies as well as for small molecule medicines; and managing manufacturing operations to ensure the safe and efficient supply of important commercial respiratory products to global patients. Steve joined GSK in 2002 following a Ph.D. and post-doctoral fellowship in organic synthetic chemistry at Harvard University.

Dr. Fogle is a fellowship-trained, board-certified specialist in the management of peripheral vascular disease (diseases of arteries and veins). He graduated from Stanford University with an AB in Human Biology, and from the UCSF School of Medicine. He subsequently earned a Master's Degree in Healthcare Management at the Harvard School of Public Health. Dr. Fogle trained in both general and vascular surgery at Brigham and Women's Hospital in Boston. Dr. Fogle became the Chief Medical Officer of Prima CARE in 2012 and is responsible for administrative issues related to the delivery of high-quality, cost-effective care. He is the Inpatient Medical Director at Saint Anne’s Hospital in Fall River and serves as a Chapter Medical Director for the Steward Health Care Network. Dr. Fogle is a member of the Syrian-American Medical Society (SAMS) and has participated in four medical missions to Jordan since 2017.

Francine Welty is an Associate Professor of Medicine at Harvard Medical School and a board-certified cardiologist at Beth Israel Deaconess Medical Center in Boston. She focuses on prevention and women’s health. Research interests include the role of inflammation in atherosclerosis, diabetes, and obesity, the use of omega-3 fatty acids in the prevention of inflammation and the emerging role of specialized pro-resolving lipid mediators, the downstream products of omega-3 fatty acids, in preventing atherosclerosis. She has a special interest in improving medical care for refugees and has an NIH grant to examine the impact of displacement by the war on diabetes and cardiovascular disease in Syrian refugees in Lebanon.

Jagpreet Chhatwal is an Assistant Professor at Harvard Medical School and Associate Director at Massachusetts General Hospital. His research is centered in decision science, data analytics, and health economics. Dr. Chhatwal is internationally recognized for his decision-analytic work to inform hepatitis C elimination efforts, and more recently, on COVID-19 mitigation in the United States. In addition, his work has informed policies to address the opioid epidemic, high-risk alcohol drinking, and screening for liver cancer. He has served as a consultant to the Department of Health and Human Services and the World Health Organization on hepatitis C elimination. He has authored/co-authored over 100 peer-reviewed scientific papers and book chapters. His work has been featured in leading media such as The Wall Street Journal, CNBC, Forbes, and National Public Radio.

Rami Alhamad is a Syrian-Canadian engineer and entrepreneur. Rami is currently the VP of Product at WHOOP, a Boston-based wearable performance tracker focused on sleep and recovery. Previously, Rami founded and ran PUSH, a leading wearable startup focused on sports performance tracking with over 150+ pro clients including multiple Olympic organizations. Rami sold PUSH in 2021 to WHOOP and has joined WHOOP's executive team since. Rami is passionate about technology, design, & business strategy.